Live·Open questions in longevity research
All grants

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)

fromNational Institutes of Health (NIH)openone off
Deadline
February 16, 2027
in 85 days
Amount
$275,000 direct costs over two years (maximum $200,000 in a single year)
About this grant

NIH R21 funding opportunity supporting exploratory and developmental research at early and conceptual project stages; clinical trial applications are not accepted. The NIH Exploratory/Developmental Research Grant Program supports novel, exploratory and developmental biomedical, behavioral, and clinical research projects that may involve considerable risk and could substantially advance their field. This R21 supports novel scientific ideas or new model systems, tools, or technologies with potential for significant impact on biomedical or biobehavioral research. Review emphasizes conceptual framework, innovation, and potential to advance knowledge; extensive background material and preliminary data are not required.

Eligibility

This funding opportunity does not accept applications proposing clinical trial(s). Applications must not propose clinical trials. Only New, Resubmission, and Revision application types are allowed for this NOFO. Non-domestic (non-U.S.) entities, including foreign organizations, are eligible to apply; non-domestic components of U.S. organizations are also eligible to apply, and foreign components are allowed. Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Program Director/Principal Investigator may work with their organization to develop an application. Applicant organizations may submit more than one application only when each application is scientifically distinct. NIH will not accept duplicate or highly overlapping applications under review at the same time.

Instructions & requirements
Deadline

Applications are due by 5:00 PM local time of the applicant organization on the applicable listed application due date.

Deadline

The funding opportunity expires January 8, 2028.

Deadline

Errors must be corrected and the changed or corrected application must be submitted to Grants.gov on or before the application due date and time; applications submitted after the deadline are considered late.

Eligibility

This funding opportunity does not accept applications proposing clinical trial(s).

Eligibility

Applications must not propose clinical trials.

Eligibility

Only New, Resubmission, and Revision application types are allowed for this NOFO.

Eligibility

Non-domestic (non-U.S.) entities, including foreign organizations, are eligible to apply; non-domestic components of U.S. organizations are also eligible to apply, and foreign components are allowed.

Eligibility

Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Program Director/Principal Investigator may work with their organization to develop an application.

Eligibility

Applicant organizations may submit more than one application only when each application is scientifically distinct.

Eligibility

NIH will not accept duplicate or highly overlapping applications under review at the same time.

Official document
Apply for this grant
More fromNational Institutes of Health (NIH)